|
PANX1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.77303999999712E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.178700E-04 |
| Normal-vs-Stage2 |
1.808990E-01 |
| Normal-vs-Stage3 |
2.735600E-03 |
| Normal-vs-Stage4 |
6.957700E-04 |
| Stage1-vs-Stage2 |
6.815800E-01 |
| Stage1-vs-Stage3 |
4.461800E-01 |
| Stage1-vs-Stage4 |
3.249800E-02 |
| Stage2-vs-Stage3 |
4.033000E-01 |
| Stage2-vs-Stage4 |
4.203800E-02 |
| Stage3-vs-Stage4 |
1.151790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.97009999997255E-06 |
| Normal-vs-AfricanAmerican |
3.480400E-01 |
| Normal-vs-Asian |
2.463600E-01 |
| Caucasian-vs-AfricanAmerican |
1.253760E-01 |
| Caucasian-vs-Asian |
9.416400E-01 |
| AfricanAmerican-vs-Asian |
4.546400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.386300E-04 |
| Normal-vs-Female |
5.89599999999413E-05 |
| Male-vs-Female |
5.753800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.127600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.999200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.80573999999378E-05 |
| Normal-vs-Age(81-100Yrs) |
4.186000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.332400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.713200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.841560E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.749900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.974000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.695000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.169700E-02 |
| Normal-vs-Grade 2 |
5.609600E-04 |
| Normal-vs-Grade 3 |
1.231690E-02 |
| Normal-vs-Grade 4 |
9.60629999999796E-05 |
| Grade 1-vs-Grade 2 |
9.900600E-01 |
| Grade 1-vs-Grade 3 |
7.901400E-01 |
| Grade 1-vs-Grade 4 |
2.819700E-02 |
| Grade 2-vs-Grade 3 |
4.175600E-01 |
| Grade 2-vs-Grade 4 |
8.162900E-03 |
| Grade 3-vs-Grade 4 |
3.357900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.279500E-03 |
| Normal-vs-ccB subtype |
1.70560000001263E-06 |
| ccA subtype-vs-ccB subtype |
2.222300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.565950E-04 |
| Normal-vs-N1 |
1.299980E-01 |
| N0-vs-N1 |
2.983800E-01 |
|
|
